| Name | Title | Contact Details |
|---|---|---|
Angela Grunte |
Global Head of Supplier Engagement | Profile |
Estiatorio Milos is a renowned restaurant group founded in 1979 by Greek restaurateur Costas Spiliadis in Montreal. It is celebrated for its authentic Greek cuisine, emphasizing high-quality, fresh ingredients. With locations in major cities like New York, Athens, Las Vegas, Miami, London, Los Cabos, and Dubai, Milos offers refined dining experiences that prioritize simplicity and the art of sharing. The restaurant specializes in Mediterranean seafood, featuring fresh fish and shellfish sourced directly from Greek fishermen. Dishes are crafted to highlight natural flavors, often using artisanal ingredients like cold-pressed Koroneiki olive oil and seasonal vegetables. Milos is known for its warm hospitality and communal dining atmosphere, making it a favorite among discerning diners and culinary enthusiasts seeking an authentic taste of Greece.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Tower Street Insurance was established to provide the most effective solutions to manage your commercial and personal risks. It is our privilege to represent and partner with each of our clients. We have built our reputation on offering successful families and businesses the highest level of service rooted in transparency and trust. With our extensive resources and exclusive carrier options, we are able to create protection strategies that provide custom solutions with the broadest coverage, superior claims service, and overall best value. However, we also understand that choosing a risk management solution involves more than simply obtaining coverage, so we go beyond offering policies backed by the best insurance companies in the business. We listen to specific needs, form solid relationships, and take the time to walk each client through all aspects of their personalized insurance plan. After the plan is in place, we continue to serve as an on-call partner devoted to our clients risk management success year-round. At Tower Street Insurance, our entire team is passionate about providing a consistently exceptional experience. Our commitment to perfection, attention to detail, and many years in the industry allow us to confidently provide a solution for all risk management and insurance needs. We hope we will have the opportunity to provide a comprehensive insurance solution for your business and family.
RESRG Automotive is a global automotive supplier formed from the merger of Rehau Automotive and SRG Global Automotive, officially launched in April 2025. Headquartered in Troy, Michigan, with a European base in Rehau, Germany, the company operates 22 production sites across multiple countries, including Germany, France, and India. With a workforce of around 10,000 employees, RESRG projects pro-forma sales of €1.7 billion. The company specializes in polymer-based exterior and functional systems, offering products such as bumpers, grilles, lamp bezels, and roof panels. RESRG employs advanced manufacturing processes like injection molding and galvanizing, focusing on combining aesthetic appeal with functional performance. The company aims to partner with leading automakers to provide innovative solutions in automotive design and technology.